18.11.2012 Views

ACTA BIOLOGICA CRACOVIENSIA

ACTA BIOLOGICA CRACOVIENSIA

ACTA BIOLOGICA CRACOVIENSIA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

16 TH INTERNATIONAL SYMPOSIUM ON CAROTENOIDS<br />

among women with higher lutein/zeaxanthin intakes. No SNPs<br />

were region-wide significantly associated with plasma β-cryptoxanthin,<br />

lycopene, or retinol. This study confirms that variants in<br />

BCMO1±20 kilobases are associated with plasma carotenoid levels<br />

and may be useful markers of carotenoid exposure in future<br />

studies.<br />

1.14.<br />

Antioxidant capacity of crude extracts of<br />

carotenoids from the berries of various<br />

cultivars of sea buckthorn<br />

Michał Kruczek1 , Adam Świderski1 ,<br />

Aleksandra Mech-Nowak 1 , Katarzyna Król2 1Department of Biochemistry, University of Agriculture in Kraków,<br />

al. 29-Listopada 54, 31-425 Kraków, Poland,<br />

kruczek.michael@gmail.com, aswider@ogr.ar.krakow.pl,<br />

aleksandra.mech.nowak@gmail.com<br />

2The Fruit Experiment Station in Brzezna, Brzezna 1, 33-386<br />

Podegrodzie, Poland, krol@brzezna.pl<br />

Comparative analysis of antioxidant capacity of crude extracts<br />

containing carotenoids obtained from fruits of sea buckthorn harvested<br />

in 2010 were conducted using FRAP (Ferric Reducing<br />

Antioxidant Power) method. The study included nine cultivars of<br />

sea buckthorn growing in the comparative cultivation at the Fruit<br />

Experiment Station in Brzezna near Nowy Sącz.<br />

In Poland, sea buckthorn fruits and preserves obtained from<br />

them are not very well known because Sea Buckthorn are encountered<br />

occasionally as ornamental tree. However sea buckthorn is<br />

more known and cultivated at Northern Europe and Asia (Mech-<br />

Nowak et al., 2011). These fruits are regarded as a valuable for<br />

health in folk medicine. Recently, more and more fruits of sea<br />

buckthorn are the feedstock for production of many emerging on<br />

the world market drugs supporting health (Stahl and Sies, 2003).<br />

Therefore, there is a need for assessment of suitability for the cultivation<br />

of sea buckthorn in Poland, that are already known in<br />

Europe, including the evaluation of health-oriented values of<br />

obtained fruits.<br />

Conducted analysis allowed to compare the antioxidant<br />

capacity of extracts of carotenoids using the spectrophotometric<br />

method of FRAP as well as DAD-HPLC methods. FRAP analysis<br />

showed that the highest antioxidant capacity was demonstrated<br />

by three of the sea buckthorn cultivars: Botanicheskaya,<br />

Avgustinka and Luchistaya. However HPLC methods provided the<br />

evidence that highest carotenoid content was observed in three<br />

other cultivars: Aromatnaya, Moskvichka and Arumnyj. Other<br />

antioxidants such as tocoferols might be involved.<br />

We thank Anna Kostecka-Gugała for consultation regarding FRAP. This<br />

work was supported by the Ministry of Science and Higher Education,<br />

grant no NN 312 252 536.<br />

REFERENCES<br />

RANJITH A et al. 2006. Fatty Acids, Tocols, and Carotenoids in Pulp Oil<br />

of Three Sea Buckthorn Species (Hippophae rhamnoides, H.<br />

salicifolia, and H. tibetana) Grown in the Indian Himalayas.<br />

STAHL W. and SIES H. 2003. Antioxidant activity of carotenoids.<br />

Molecular Aspects of Medicine 24: 345-351.<br />

MECH-NOWAK A, ŚWIDERSKI A, KROL K. 2011. Carotenoid content in<br />

berries of selected cultivars of sea buckthorn (Hippophae rhamnoides<br />

L.) grown in the Malopolska province in Poland, VII<br />

International Scientific Conference, Lviv, abstract book, 338-339.<br />

1.15.<br />

Infant plasma response to lutein in formula<br />

and human milk<br />

Pamela Price, Amy Mackey, Jeffery Oliver, Daniel Albrecht,<br />

Matthew J. Kuchan<br />

Abbott Nutrition, 3300 Stelzer Road Columbus, OH 43219 USA,<br />

Pamela.Price@abbott.com, Amy.Mackey@abbott.com,<br />

Jeffery.Oliver@abbott.com, Daniel.Albrecht@abbott.com,<br />

Matthew.Kuchan@abbott.com<br />

Wide variations of lutein in human milk exist and are generally<br />

reflective of maternal dietary intake. Information is lacking regarding<br />

appropriate lutein supplementation levels in infant formula<br />

that result in plasma levels comparable to the breastfed infant.<br />

The objective of this study was to measure infant plasma response<br />

to lutein supplementation of infant formula. Term infants (n=28)<br />

enrolled in a controlled clinical trial, that was non-randomized<br />

and unblinded, were fed formula containing 117 μg lutein/L. The<br />

level of lutein in the formula was chosen based on plasma<br />

carotenoid responses in infants fed carotenoid-supplemented formula<br />

from phase one of this study (Mackey et al., 2008). Lutein<br />

intake and plasma response were measured at baseline and after<br />

56 days of feeding. Statistical comparisons were made between<br />

infants fed the experimental formula and those in an exclusively<br />

breastfed group from the phase one study. Anthropometric data<br />

were collected on study days 1, 28, and 56. At baseline, mean plasma<br />

lutein levels were significantly higher in the breastfed group<br />

than in the formula-fed group. After 56 days of feeding, infants fed<br />

the lutein-containing formula had significantly greater mean plasma<br />

concentration of lutein than human milk-fed infants; however,<br />

the range of plasma lutein in the formula-fed infants was within<br />

the range of the human milk-fed infants as reported by both<br />

Mackey et al., 2008 and Bettler et al., 2010. Anthropometric data<br />

and the reported incidence of adverse events in the formula-fed<br />

group were similar to other formulas fed in phase one. Results<br />

from both phases of the clinical study indicate that the carotenoidsupplemented<br />

formulas were safe and well tolerated. This work<br />

provides evidence that 117 μg lutein/L, needed in formula to<br />

achieve the range of plasma levels corresponding to that of human<br />

milk-fed infants, is safe and well tolerated.<br />

REFERENCES<br />

MACKEY A, PRICE P, OLIVER J, ALBRECHT D, BOILEAU A. 2008. Relative<br />

bioavailability of carotenoids in infant formula and human milk.<br />

Presented at Clinical Nutrition Week, Chicago.<br />

BETTLER J, ZIMMER JP, NEURINGER M, DERUSSO PA. 2010. Serum lutein<br />

concentrations in healthy term infants fed human milk or infant<br />

formula with lutein. Eur J Nutr 49: 45-51.<br />

1.16.<br />

Northern berries as source of carotenoids<br />

useful for maintenance of human health<br />

Katya A. Lashmanova1 , Olga A. Kuzivanova2 ,<br />

Olga V. Dymova2 SESSION 1<br />

1 Faculty of Chemistry and Biology, Syktyvkar State University,<br />

Petrosavodskaya st., 120, 167005 Syktyvkar, Russia, ekaterinalashmanova@yandex.ru<br />

2 Institute of Biology, Komi Science Centre, Ural Branch of Russian<br />

Academy of Sciences, Kommunisticheskaya st., 28, 167982,<br />

Syktyvkar, Russia, dymovao@ib.komisc.ru<br />

Carotenoids are bioactive substances in foods with powerful<br />

antioxidant bioactivity. There are abundant data showing theirs<br />

preventive effects in humans for number of diseases. Due to the<br />

26 <strong>ACTA</strong> <strong>BIOLOGICA</strong> <strong>CRACOVIENSIA</strong> Series Botanica

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!